BRQWQ - SODIUM IODIDE I 131 THERAPEUTIC CAPSULES
- MSDS: BRQWQ
- Manufacturer: MALLINCKRODT
- Product Name: SODIUM IODIDE I 131 THERAPEUTIC CAPSULES
- National Stock Number: 6505-00N040070
Product Identification
Product ID:SODIUM IODIDE I 131 THERAPEUTIC CAPSULES
MSDS Date:01/01/1992
FSC:6505
NIIN:00N040070
MSDS Number: BRQWQ
Responsible Party
MARYLAND HEIGHTS, MO 63043
US
Emergency Phone: 314-344-3800
Info Phone: 314-344-3800
Cage: ZA916
Contractor
Telephone: 314-770-7800
Cage: ZA916
Ingredients
CAN POTNTLY CAUSE HARMFUL BIOLOGICAL EFTS WHICH INCL
RTECS: 9999999ZZ
UPTAKE OF I-131 CAN RESULT IN SLIGHT TO TOTAL THYROID
RTECS: 9999999ZZ
SODIUM IODIDE
CAS: 7790-26-3
Fraction By Weight: <0.001%
1);(SODIUM PHOSPHATE,
CAS: 7558-79-4
RTECS: WC4500000
Fraction By Weight: 93.6%
EPA Report Quantity: 5000 LBS
DOT Report Quantity: 5000 LBS
CAP VIAL, ODORLESS.
RTECS: 9999999ZZ
BELIEVED TO INVOLVE LEVELS OF RADIA EXPOS
RTECS: 9999999ZZ
IT IS WIDELY ACCEPTED BY THE SCIENTIFIC
RTECS: 9999999ZZ
POTNTLY CAUSE HARMFUL BIOLOGICAL EFTS WHICH INCL
RTECS: 9999999ZZ
IT IS WIDELY ACCEPTED BY THE SCIENTIFIC
RTECS: 9999999ZZ
Hazards
LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:THE HAZARDOUS, NON-RADIOACTIVE
INGREDIENTS FOUND IN SODIUM IODIDE I-131 DIAGNOSTIC CAPSULES ARE
SKIN & EYE IRRITANTS, BUT DUE TO THE SMALL QUANTITIES PRESENT IN
EACH CONTAINER, NO ADVERSE EFFECTS ARE EXPECTED TO OCCUR FROM
THESE COMPONENTS. INHAL:IN MOIST AIR, VERY SMALL FRACTION OF SODIUM
IODIDE I-131(EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ:MAY BREAK DOWN & EMIT RADIOACTIVE
FUMES. NOT EXPECTED TO BE A HLTH HAZ. INGEST:MAY CAUSE ASYMPTOMATIC
PHYSIOLOGICAL UPTAKE BY THYROID GLAND OR OTHER TISS. EYE:MAY CAUSE
MECHANICAL IRRITATIONS . CHRONIC:THE HEALTH RISKS ASSOC W/CHRONIC
RADIA EXPOS (CANCER, LEUKEMIA, GENETIC & TERATOGENIC EFTS) ARE (ING
4)
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.
First Aid
First Aid:INHAL:MOVE TO FRESH AIR. SUPPORT BREATHING (GIVE O*2/ARTF
RESP) . INGEST:NOTIFY RADIA SAFETY PERS IMMED. THE AMOUNT IF I-131
IN THYROID GLAND SHOULD BE ASSESSED & DOCUMENTED. A THYROID
BLOCKING AGENT MAY BE WARRANTED & GIVEN UNDER DIRECT SUPERVISION
OF MD. SKIN:WASH AREA THORO W/SOAP & WATER UNTIL NO MORE
RADIOACTIVITY CAN BE REMOVED. ALWAYS BLOT DRY. DO NOT ABRADE SKIN.
NOTIFY (SUPDAT)
Fire Fighting
Extinguishing Media:USE ANY MEANS SUITABLE FOR EXTINGUISHING
SURROUNDING FIRE.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:NOT CONSIDERED TO BE A FIRE OR EXPLOSION
HAZARD.
Accidental Release
Spill Release Procedures:IF PRODUCT IS RECIEVED IN LEAKING CNDTN OR ANY
LOSS OR RELS OF RADIOACTIVE CONTENTS OCCURS, NOFITY YOUR RADIATION
SAFETY DEPT & MALLINCKRODT. ALL CLEANUP OPERS SHOULD BE PERFORMED
ACCORDING TO STANDAR D OPERATING PROC ESTABLISHED FOR YOUR (SUPDAT)
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
Handling
Handling and Storage Precautions:STORE AT 15-30C. HANDLING TIME SHOULD
BE KEPT TO A MINIMUM, AND APPROPRIATE SHIELDING SHOULD BE USED.
HANDLING DEVICES SUCH AS TONGS SHOULD BE USED.
Other Precautions:STORAGE AND DISPOSAL OF PRODUCT SHOULD BE CONTROLLED
IN A MANNER WHICH IS IN COMPLIANCE WITH THE APPROPRIATE REGULATIONS
OF THE FEDERAL OR STATE GOVERNMENT AGENCY AUTHORIZED TO LICENSE THE
USE OF THIS RADIONUCLIDE.
Exposure Controls
Respiratory Protection:NIOSH/MSHA APPROVED RESPIRATOR APPROPRIATE FOR
EXPOSURE OF CONCERN .
Ventilation:PROPERLY SEALED CONTAINERS ARE NOT EXPECTED TO REQUIRE ANY
SPECIAL VENTILATION.
Protective Gloves:DISPOSABLE PLASTIC, LATEX OR RUBBER.
Eye Protection:CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:LAB COAT.
Work Hygienic Practices:NO SMOKING, EATING OR DRINKING SHOULD BE
ALLOWED IN ANY AREA WHERE RADIOACTIVE MATERIALS ARE HANDLED OR
STORED.
Supplemental Safety and Health
SPILL PROC:FACILITY. RADIOACTIVE WASTE SHOULD BE DISPOSED OF ACCORDING
TO SOP'S ESTABLISHED BY YOUR RADIATION SAFETY OFFICER. FIRST AID
PROC:RADIATION SAFETY PERSONNEL. EYE:WASH W/WATER FOR AT LEAST 1 5
MINUTES OR UNTIL NO MORE RADIOACTIVITY CAN BE REMOVED. NOTIFY
RADIATION SAFETY PERSONNEL.
Chemical Properties
Solubility in Water:DISSOLVES
Appearance and Odor:OPAQUE, WHITE GELATIN CAPSULES, IN A 10 ML
FRENCH-SQUARE GLASS, SCREW (ING 3)
Stability
Stability Indicator/Materials to Avoid:YES
NONE SPECIFIED BY MANUFACTURER.
Stability Condition to Avoid:IN PRESENCE OF MOIST AIR, A VERY SMALL
FRACTION OF THE PRODUCT MAY BREAK DOWN AND EMIT RADIOACTIVE FUMES
CNTNG I-131.
Hazardous Decomposition Products:MAY EMIT RADIOACTIVE FUMES CONTAINING
I-131 WHEN HEATED TO DECOMPOSITION.
Disposal
Waste Disposal Methods:ENSURE COMPLINACE WITH LOCAL, STATE AND FEDERAL
REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.